These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6117103)

  • 1. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 7. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
    [No Abstract]   [Full Text] [Related]  

  • 8. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 10. Nongenetic factors affecting human platelet monoamine oxidase [proceedings].
    Friedhoff AJ; Miller JC
    Psychopharmacol Bull; 1981 Jan; 17(1):101-3. PubMed ID: 6112772
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 13. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 17. [Decrease in the thrombocyte monoamine oxidase activity of schizophrenic patients].
    Kurilova II; Lideman RR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1351-4. PubMed ID: 706910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet MAO activity in major psychoses.
    Gattaz WF
    Mod Probl Pharmacopsychiatry; 1983; 19():315-20. PubMed ID: 6135152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.